Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.
about
Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysisGalectin-3 as a marker and potential therapeutic target in breast cancerInhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide.Immunophenotypes of glycogen rich clear cell carcinoma.Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytomaIncidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia.Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.
P2860
Q26823419-BA28E3C8-CBB7-449A-BDA9-0A0EFAD72A15Q34257030-D8D2541F-21AC-4466-B3C4-7AF5C0B5BB7DQ34360666-069FDC96-B851-4861-AF66-3A7740B71D91Q34449110-418A7953-DE52-4984-98D3-DA4F7431582DQ36208118-5B4F602C-6963-414F-A7BB-7D59A77DA029Q36365067-372E88CB-C689-4AE0-A3DF-EB0D45C0FC4CQ37126786-8BD3E924-C4CC-4FE4-A1BB-A427273EB7A6Q40346833-F98B5A87-9400-4657-BDA4-7FFFDA0D07CBQ42233793-4BBC76E3-8D07-44F4-8191-3789AFFDCD97Q47329197-6901BA0A-02D2-44A3-8E4D-96933A7B36C4Q53183087-B9B28365-BFF1-4AD1-802A-C288BE333424
P2860
Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@ast
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@en
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@nl
type
label
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@ast
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@en
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@nl
prefLabel
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@ast
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@en
Clinicopathlogic and immunohis ...... ve invasive lobular carcinoma.
@nl
P2860
P356
P1476
Clinicopathlogic and immunohis ...... ive invasive lobular carcinoma
@en
P2093
Woohee Jung
P2860
P356
10.3349/YMJ.2011.52.1.89
P50
P577
2011-01-01T00:00:00Z